Fulcrum Therapeutics Social Media Community Guidelines
Our social media profiles including Twitter, Facebook, LinkedIn, and Instagram provide exciting opportunities to connect and interact with individuals and organizations interested in Fulcrum Therapeutics. We intend to use these platforms to share company news, activities, and announcements, provide corporate information and live updates from medical conferences, and participate in important community outreach and advocacy efforts.
It is our goal to interact with as many social media users as possible when appropriate, but please note we may not be able to reply individually to all messages received on these platforms. We want to ensure these channels continue to be a safe, helpful and positive resource for visitors. We reserve the right to block or mute users posting inappropriate or offensive material at our sole discretion, with or without notice.
We work in a highly regulated healthcare industry and may often be unable to engage in some discussions about products and will not offer medical advice using social media. Please note social media posts by independent users do not necessarily reflect the views of our company and might contain information on products which may or may not be available in any particular country, and if available, have received approval or market clearance by a governmental regulatory body for different indications and restrictions in different countries. We do not control or endorse this third-party content and makes no representations regarding its accuracy. Visit https://www.fulcrumtx.com/ or contact us via email at [email protected] or by phone at 617-651-8851 to obtain the appropriate product information for your country of residence.
If you believe you have experienced an adverse event related to our products, please contact your healthcare provider immediately. You are also encouraged to report negative side effects to the U.S. Food and Drug Administration (FDA) by visiting MedWatch or calling 1-800-FDA-1088. If you post information on social media about an adverse event, please note we may be required to contact you for additional information to comply with regulatory guidelines.
Thank you for reading our Community Guidelines and for following Fulcrum Therapeutics on social media.